Litcius/Paper detail

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy

Yubo Wang, Nong Yang, Yongchang Zhang, Li Li, Rui Han, Mengxiao Zhu, Mingxia Feng, Hengyi Chen, Analyn Lizaso, Qin Tian, Xiaoyan Liu, Yong He

2020Journal of Thoracic Oncology102 citationsDOI

Topics & Concepts

MedicineT790MOsimertinibCetuximabLung cancerOncologyInternal medicineCombination therapyChemotherapyAdenocarcinomaCancerColorectal cancerROS1Lung Cancer Treatments and MutationsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Diagnosis and Treatment
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy | Litcius